Manolios, N.
48  Ergebnisse:
Personensuche X
?
2

99mTc-labelled glucosamine in the assessment of systemic sc..:

Englert, H. ; Richards, BL. ; Angelides, S....
Annals of Nuclear Medicine.  35 (2021)  10 - p. 1157-1166 , 2021
 
?
4

Novel T-cell inhibiting peptides delay the onset of Type 1 ..:

Wong, M.S. ; Tso, A. ; Ali, M...
Diabetes & Metabolism.  40 (2014)  3 - p. 229-234 , 2014
 
?
6

Assessing Cognitive Function in Rheumatoid Arthritis: Comme..:

Meade, T. ; Manolios, N.
Arthritis Care & Research.  65 (2013)  8 - p. 1390-1390 , 2013
 
?
 
?
 
?
9

Antitopoisomerase antibody positivity predates nailfold cap..:

Englert, H. ; Champion, D. ; Wu, J. C....
Internal Medicine Journal.  41 (2011)  2 - p. 197-199 , 2011
 
?
11

Familial scleroderma: nature, nurture or both?:

Englert, H. ; Roberts‐Thomson, P. J. ; Byth, K..
Internal Medicine Journal.  38 (2008)  4 - p. 235-242 , 2008
 
?
13

Autologous stem cell transplantation in diffuse scleroderma..:

Englert, H. ; Kirkham, S. ; Moore, J....
Internal Medicine Journal.  38 (2008)  9 - p. 692-696 , 2008
 
?
14

Lack of increased expression of cell surface markers for ci..:

Russo, R. ; Medbury, H. ; Guiffre, A...
Clinical Rheumatology.  26 (2006)  7 - p. 1136-1141 , 2006
 
?
15

Discrepancy in CD3‐Transmembrane Peptide Activity between I..:

Collier, S. ; Bolte, A. ; Manolios, N.
Scandinavian Journal of Immunology.  64 (2006)  4 - p. 388-391 , 2006
 
1-15